LENZ THERAPEUTICS INC (LENZ) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:LENZ • US52635N1037

15.82 USD
-1.96 (-11.02%)
At close: Jan 30, 2026
16.1 USD
+0.28 (+1.77%)
After Hours: 1/30/2026, 8:01:53 PM
Fundamental Rating

3

LENZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While LENZ has a great health rating, there are worries on its profitability. LENZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year LENZ has reported negative net income.
  • LENZ had a negative operating cash flow in the past year.
  • In the past 5 years LENZ always reported negative net income.
  • In the past 5 years LENZ always reported negative operating cash flow.
LENZ Yearly Net Income VS EBIT VS OCF VS FCFLENZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -24.11%, LENZ is in line with its industry, outperforming 57.59% of the companies in the same industry.
  • LENZ has a Return On Equity of -25.39%. This is in the better half of the industry: LENZ outperforms 63.87% of its industry peers.
Industry RankSector Rank
ROA -24.11%
ROE -25.39%
ROIC N/A
ROA(3y)-40.22%
ROA(5y)-88.15%
ROE(3y)-42.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LENZ Yearly ROA, ROE, ROICLENZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for LENZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LENZ Yearly Profit, Operating, Gross MarginsLENZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

9

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, LENZ has more shares outstanding
  • The number of shares outstanding for LENZ has been reduced compared to 5 years ago.
  • There is no outstanding debt for LENZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LENZ Yearly Shares OutstandingLENZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LENZ Yearly Total Debt VS Total AssetsLENZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 26.16 indicates that LENZ is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 26.16, LENZ belongs to the top of the industry, outperforming 89.53% of the companies in the same industry.
  • There is no outstanding debt for LENZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26.16
ROIC/WACCN/A
WACCN/A
LENZ Yearly LT Debt VS Equity VS FCFLENZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 20.54 indicates that LENZ has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 20.54, LENZ belongs to the best of the industry, outperforming 90.05% of the companies in the same industry.
  • LENZ has a Quick Ratio of 20.54. This indicates that LENZ is financially healthy and has no problem in meeting its short term obligations.
  • LENZ has a better Quick ratio (20.54) than 90.05% of its industry peers.
Industry RankSector Rank
Current Ratio 20.54
Quick Ratio 20.54
LENZ Yearly Current Assets VS Current LiabilitesLENZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

  • LENZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.60%, which is quite impressive.
EPS 1Y (TTM)70.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y43.37%
EPS Next 2Y17.71%
EPS Next 3Y22.36%
EPS Next 5Y24.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LENZ Yearly Revenue VS EstimatesLENZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
LENZ Yearly EPS VS EstimatesLENZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • LENZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LENZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LENZ Price Earnings VS Forward Price EarningsLENZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LENZ Per share dataLENZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • LENZ's earnings are expected to grow with 22.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.71%
EPS Next 3Y22.36%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for LENZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

LENZ THERAPEUTICS INC / LENZ FAQ

Can you provide the ChartMill fundamental rating for LENZ THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 3 / 10 to LENZ.


Can you provide the valuation status for LENZ THERAPEUTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to LENZ THERAPEUTICS INC (LENZ). This can be considered as Overvalued.


Can you provide the profitability details for LENZ THERAPEUTICS INC?

LENZ THERAPEUTICS INC (LENZ) has a profitability rating of 1 / 10.